Cargando…

A diagnostic model of autoimmune hepatitis in unknown liver injury based on noninvasive clinical data

All the diagnostic criteria of autoimmune hepatitis (AIH) include histopathology. However, some patients may delay getting this examination due to concerns about the risks of liver biopsy. Therefore, we aimed to develop a predictive model of AIH diagnostic that does not require a liver biopsy. We co...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Haiyan, Huang, Lingying, Xie, Ying, Bai, Mei, Lu, Huili, Zhao, Shiju, Gao, Yueqiu, Hu, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006218/
https://www.ncbi.nlm.nih.gov/pubmed/36899037
http://dx.doi.org/10.1038/s41598-023-31167-w
_version_ 1784905264889069568
author Yang, Haiyan
Huang, Lingying
Xie, Ying
Bai, Mei
Lu, Huili
Zhao, Shiju
Gao, Yueqiu
Hu, Jianjun
author_facet Yang, Haiyan
Huang, Lingying
Xie, Ying
Bai, Mei
Lu, Huili
Zhao, Shiju
Gao, Yueqiu
Hu, Jianjun
author_sort Yang, Haiyan
collection PubMed
description All the diagnostic criteria of autoimmune hepatitis (AIH) include histopathology. However, some patients may delay getting this examination due to concerns about the risks of liver biopsy. Therefore, we aimed to develop a predictive model of AIH diagnostic that does not require a liver biopsy. We collected demographic, blood, and liver histological data of unknown liver injury patients. First, we conducted a retrospective cohort study in two independent adult cohorts. In the training cohort (n = 127), we used logistic regression to develop a nomogram according to the Akaike information criterion. Second, we validated the model in a separate cohort (n = 125) using the receiver operating characteristic curve, decision curve analysis, and calibration plot to externally evaluate the performance of this model. We calculated the optimal cutoff value of diagnosis using Youden’s index and presented the sensitivity, specificity, and accuracy to evaluate the model in the validation cohort compared with the 2008 International Autoimmune Hepatitis Group simplified scoring system. In the training cohort, we developed a model to predict the risk of AIH using four risk factors—The percentage of gamma globulin, fibrinogen, age, and AIH-related autoantibodies. In the validation cohort, the areas under the curve for the validation cohort were 0.796. The calibration plot suggested that the model had an acceptable accuracy (p > 0.05). The decision curve analysis suggested that the model had great clinical utility if the value of probability was 0.45. Based on the cutoff value, the model had a sensitivity of 68.75%, a specificity of 76.62%, and an accuracy of 73.60% in the validation cohort. While we diagnosed the validated population by using the 2008 diagnostic criteria, the sensitivity of prediction results was 77.77%, the specificity was 89.61% and the accuracy was 83.20%. Our new model can predict AIH without a liver biopsy. It is an objective, simple and reliable method that can effectively be applied in the clinic.
format Online
Article
Text
id pubmed-10006218
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100062182023-03-12 A diagnostic model of autoimmune hepatitis in unknown liver injury based on noninvasive clinical data Yang, Haiyan Huang, Lingying Xie, Ying Bai, Mei Lu, Huili Zhao, Shiju Gao, Yueqiu Hu, Jianjun Sci Rep Article All the diagnostic criteria of autoimmune hepatitis (AIH) include histopathology. However, some patients may delay getting this examination due to concerns about the risks of liver biopsy. Therefore, we aimed to develop a predictive model of AIH diagnostic that does not require a liver biopsy. We collected demographic, blood, and liver histological data of unknown liver injury patients. First, we conducted a retrospective cohort study in two independent adult cohorts. In the training cohort (n = 127), we used logistic regression to develop a nomogram according to the Akaike information criterion. Second, we validated the model in a separate cohort (n = 125) using the receiver operating characteristic curve, decision curve analysis, and calibration plot to externally evaluate the performance of this model. We calculated the optimal cutoff value of diagnosis using Youden’s index and presented the sensitivity, specificity, and accuracy to evaluate the model in the validation cohort compared with the 2008 International Autoimmune Hepatitis Group simplified scoring system. In the training cohort, we developed a model to predict the risk of AIH using four risk factors—The percentage of gamma globulin, fibrinogen, age, and AIH-related autoantibodies. In the validation cohort, the areas under the curve for the validation cohort were 0.796. The calibration plot suggested that the model had an acceptable accuracy (p > 0.05). The decision curve analysis suggested that the model had great clinical utility if the value of probability was 0.45. Based on the cutoff value, the model had a sensitivity of 68.75%, a specificity of 76.62%, and an accuracy of 73.60% in the validation cohort. While we diagnosed the validated population by using the 2008 diagnostic criteria, the sensitivity of prediction results was 77.77%, the specificity was 89.61% and the accuracy was 83.20%. Our new model can predict AIH without a liver biopsy. It is an objective, simple and reliable method that can effectively be applied in the clinic. Nature Publishing Group UK 2023-03-10 /pmc/articles/PMC10006218/ /pubmed/36899037 http://dx.doi.org/10.1038/s41598-023-31167-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Yang, Haiyan
Huang, Lingying
Xie, Ying
Bai, Mei
Lu, Huili
Zhao, Shiju
Gao, Yueqiu
Hu, Jianjun
A diagnostic model of autoimmune hepatitis in unknown liver injury based on noninvasive clinical data
title A diagnostic model of autoimmune hepatitis in unknown liver injury based on noninvasive clinical data
title_full A diagnostic model of autoimmune hepatitis in unknown liver injury based on noninvasive clinical data
title_fullStr A diagnostic model of autoimmune hepatitis in unknown liver injury based on noninvasive clinical data
title_full_unstemmed A diagnostic model of autoimmune hepatitis in unknown liver injury based on noninvasive clinical data
title_short A diagnostic model of autoimmune hepatitis in unknown liver injury based on noninvasive clinical data
title_sort diagnostic model of autoimmune hepatitis in unknown liver injury based on noninvasive clinical data
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006218/
https://www.ncbi.nlm.nih.gov/pubmed/36899037
http://dx.doi.org/10.1038/s41598-023-31167-w
work_keys_str_mv AT yanghaiyan adiagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT huanglingying adiagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT xieying adiagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT baimei adiagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT luhuili adiagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT zhaoshiju adiagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT gaoyueqiu adiagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT hujianjun adiagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT yanghaiyan diagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT huanglingying diagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT xieying diagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT baimei diagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT luhuili diagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT zhaoshiju diagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT gaoyueqiu diagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata
AT hujianjun diagnosticmodelofautoimmunehepatitisinunknownliverinjurybasedonnoninvasiveclinicaldata